Applied Molecular Transport Inc (AMTI)

Etorro trading 970x250

About Applied Molecular Transport Inc

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company’s lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It is also involved in developing AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase Ia clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. Address: 1 Tower Place, South San Francisco, CA, United States, 94080

Applied Molecular Transport Inc News and around…

Latest news about Applied Molecular Transport Inc (AMTI) common stock and company :

Analysts See 28% Gains Ahead For The Holdings of VXF
10 Jan, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Extended Market ETF (VXF), we found that the implied analyst target price for the ETF based upon its underlying holdings is $224.16 per unit.

56 Biggest Movers From Friday
29 Nov, 2021 FinancialContent

Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been ...

12 Health Care Stocks Moving In Friday's Intraday Session
26 Nov, 2021 FinancialContent

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 115.09% to $21.94 during Friday's regular session. As of ...

Applied Molecular Transport to Present at Virtual Jefferies London Healthcare Conference
15 Nov, 2021 Yahoo! Finance

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Bittoo Kanwar, M.D., chief medical officer, and Liz Bhatt, chief business and strategy officer, will participate in a fireside chat during the Virtual Jefferies London Healthcare Conference on Thursday, November 18, 2021 at 8:00 a.m. GMT. To access the archived recording of the fireside chat, please visit the Events

Applied Molecular Transport Reports Third Quarter 2021 Financial Results and Provides Corporate Update
10 Nov, 2021 Yahoo! Finance

Top-line data readout for oral AMT-101 Phase 2 MARKET combination trial with anti-TNFα in ulcerative colitis (UC) expected in H1 2022 Top-line data readouts from three additional oral AMT-101 Phase 2 trials, consistent with previous guidance FILLMORE monotherapy trial in pouchitis in H1 2022LOMBARD monotherapy trial in UC in H1 2022CASTRO combination trial with anti-TNFα in rheumatoid arthritis (RA) in H2 2022 Phase 1 enrollment ongoing for second product candidate, oral AMT-126, with program up

Analysts Anticipate 12% Gains Ahead For SMMV
08 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $44.05 per unit.

51 Biggest Movers From Friday
18 Oct, 2021 FinancialContent

Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on ...

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
15 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of ...

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Applied Molecular Transport to Host Virtual Research & Development Day on October 15, 2021
11 Oct, 2021 Yahoo! Finance

Management to highlight novel oral biologics technology platform, clinical programs and research activities Feature distinguished IBD and rheumatology key opinion leaders Provide update on the four on-going Phase 2 clinical trials for oral AMT-101 SOUTH SAN FRANCISCO, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company will host a virtual Research & Development Day on Friday,

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

Applied Molecular Transport Announces Upcoming Investor Events in September and October
17 Sep, 2021 FinancialContent
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
17 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
16 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
15 Sep, 2021 Yahoo! Finance

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors
24 Aug, 2021 FinancialContent
Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update
10 Aug, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's Pre-Market Session
09 Aug, 2021 FinancialContent

Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 30.38% to $2.36 during Monday's pre-market session. The ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
06 Aug, 2021 FinancialContent

Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The ...

Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference
05 Aug, 2021 FinancialContent
Analysts See 11% Upside For The Holdings of SMMV
04 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $42.05 per unit.

Relative Strength Alert For Applied Molecular Transport
22 Jul, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Investors Snag AMTI Even Cheaper Than Its Secondary Stock Offering
12 Jul, 2021 FinancialContent

Looking back to 103 days ago, Applied Molecular Transport Inc (AMTI) priced a 2,500,000 share secondary stock offering at $42.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..

Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress
09 Jul, 2021 FinancialContent
Applied Molecular Transport Breaks Below 200-Day Moving Average - Notable for AMTI
07 Jul, 2021 FinancialContent

In trading on Wednesday, shares of Applied Molecular Transport Inc (AMTI) crossed below their 200 day moving average of $41.97, changing hands as low as $41.52 per share. Applied Molecular Transport Inc shares are currently trading down about 2.8% on the day..

Look Under The Hood: DWAS Has 13% Upside
30 Jun, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco DWA SmallCap Momentum ETF (DWAS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $100.79 per unit.

Stocks With Rising Relative Strength: AppliedMolecularTrans
29 Jun, 2021 FinancialContent

AppliedMolecularTrans shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Applied Molecular Transport Inc (AMTI) is a NASDAQ Common Stock listed in , ,

970x250